The 2022 Special Session I, Assembly, Chapter 2 (approved June 22, 2022), Item 127 provides funding for the Virginia Biosciences Health Research Corporation (VBHRC), a 501(c)(3) non-stock corporation, to serve as a research consortium and catalyst to accelerate and focus in the biosciences research at Virginia’s universities (J.1).

This item also includes the requirement that you are provided, by October 1 of each year, a written report summarizing the activities of the VBHRC consortium. The report is to include a summary of how any funds disbursed to the consortium during the previous fiscal year were spent, and the consortium’s progress during the fiscal year in expanding upon existing research opportunities and stimulating new research opportunities in the Commonwealth (J.6).

We are pleased to submit to you the following report to detail progress made on core objectives, with a focus on the results achieved during Fiscal Year 2023. Please note, as with our prior annual reports, we are continuing our practice of including details of ongoing efforts into the current fiscal year.